A Phase 1, Open Label Two Period Crossover Study To Investigate The Effects Of Multiple Oral Doses Of Filibuvir On The Steady State Pharmacokinetics Of Oral Contraceptive Steroids In Healthy Female Subjects.
Phase of Trial: Phase I
Latest Information Update: 28 Apr 2011
At a glance
- Drugs Ethinylestradiol/levonorgestrel; Filibuvir
- Indications Pregnancy; Viral infections
- Focus Pharmacokinetics
- Sponsors Pfizer
- 28 Apr 2011 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
- 01 Feb 2011 Planned end date changed from Jan 2011 to Feb 2011 as reported by ClinicalTrials.gov.
- 03 Jan 2011 Planned End Date changed from 1 Dec 2010 to 1 Jan 2011 as reported by ClinicalTrials.gov.